Clinical Trial Update: Evaluation of the Efficacy and Safety of Single Dose Tranexamic Acid in Reducing Blood Loss During Colorectal Cancer Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of a single-dose tranexamic acid to reduce blood loss during colorectal cancer surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Surgery

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Assiut University | Conditions: Colorectal Surgery | Phase 4 | Status: COMPLETED